Study of Risk Marker in CAD Patients

Míreanna Comhchosúla

• Risk Evaluation of Hepatocellular Carcinoma Using AFP as a Marker in Viral Hepatitis Patients
  le: Megha P.C
  Foilsithe: (2012)
• Comparative Study of HDL Cholesterol and APO-A1 in CAD Patients with or without Type 2 Diabetes
  le: Minusha C.
  Foilsithe: (2007)
• Serum Ferritin as a Risk Marker for Type2 Diabetic Coplications
  le: Surabhi C.
  Foilsithe: (2012)
• Comparative Study of Cardiac Markers such as Troponin T, CK-MB and CK in Myocardial Infarction Patients with and without Diabetes Mellitus
  le: Gopinath Pantharapadi
  Foilsithe: (2007)
• Organic Acids as Markers of Metabolic Disorders
  le: Nisha P.
  Foilsithe: (2007)